Nephros (NEPH) EBT Margin (2010 - 2026)
Nephros' quarterly EBT Margin came in at 2.48% in Q1 2026, down 940.0% year-on-year from 0.29% in Q1 2025, and up 88.78% quarter-over-quarter from 1.31% in Q4 2025.
Nephros has reported EBT Margin for 17 years, with the latest figure at 2.48% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 940.0% year-over-year to 2.48%; the trailing twelve-month figure through Mar 2026 stood at 4.06% (down 133.0% YoY), and the FY2025 full-year result was 6.42%, up 579.0% from the prior year.
- EBT Margin for Q1 2026 stood at 2.48%, up from 1.31% in the prior quarter.
- The five-year high for EBT Margin was 11.87% in Q1 2025, with the low at 71.98% in Q1 2022.
- Average EBT Margin over 5 years is 11.52%, with a median of 5.13% recorded in 2023.
- Year-over-year, EBT Margin tumbled 3440 bps in 2022 and soared 6400 bps in 2023.
- Tracing NEPH's EBT Margin over 5 years: stood at 26.94% in 2022, then grew by 29 bps to 19.11% in 2023, then surged by 149 bps to 9.41% in 2024, then tumbled by 86 bps to 1.31% in 2025, then jumped by 89 bps to 2.48% in 2026.
- The last three EBT Margin figures came in at 2.48% (Q1 2026), 1.31% (Q4 2025), and 7.14% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 33.94% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 0.83% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 35.09% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 21.32% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.80% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 18.77% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 14.31% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -0.22% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 9.54% |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 2.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48% |
| Dec 31, 2025 | 1.31% |
| Sep 30, 2025 | 7.14% |
| Jun 30, 2025 | 5.57% |
| Mar 31, 2025 | 11.87% |
| Dec 31, 2024 | 9.41% |
| Sep 30, 2024 | 5.20% |
| Jun 30, 2024 | -8.89% |
| Mar 31, 2024 | -5.00% |
| Dec 31, 2023 | -19.11% |
| Sep 30, 2023 | -5.13% |
| Jun 30, 2023 | -11.90% |
| Mar 31, 2023 | -7.98% |
| Dec 31, 2022 | -26.94% |
| Sep 30, 2022 | -53.18% |
| Jun 30, 2022 | -28.74% |
| Mar 31, 2022 | -71.98% |
| Dec 31, 2021 | -26.76% |
| Sep 30, 2021 | -31.42% |
| Jun 30, 2021 | -49.65% |
| Mar 31, 2021 | -37.57% |
| Dec 31, 2020 | -31.32% |
| Sep 30, 2020 | -44.84% |
| Jun 30, 2020 | -102.98% |
| Mar 31, 2020 | -42.23% |
| Dec 31, 2019 | -10.95% |
| Sep 30, 2019 | -24.01% |
| Jun 30, 2019 | -39.58% |
| Mar 31, 2019 | -76.14% |
| Dec 31, 2018 | -46.77% |
| Sep 30, 2018 | -31.44% |
| Jun 30, 2018 | -49.78% |
| Mar 31, 2018 | -122.64% |
| Dec 31, 2017 | -37.38% |
| Sep 30, 2017 | -66.05% |
| Jun 30, 2017 | -88.82% |
| Mar 31, 2017 | -97.10% |
| Dec 31, 2016 | -90.07% |
| Sep 30, 2016 | -172.24% |
| Jun 30, 2016 | -166.21% |
| Mar 31, 2016 | -150.28% |
| Dec 31, 2015 | -265.55% |
| Sep 30, 2015 | -342.50% |
| Jun 30, 2015 | -106.35% |
| Mar 31, 2015 | -155.03% |
| Dec 31, 2014 | -291.23% |
| Sep 30, 2014 | -250.34% |
| Jun 30, 2014 | -148.07% |
| Mar 31, 2014 | -160.04% |
| Dec 31, 2013 | 152.95% |
| Sep 30, 2013 | -146.65% |
| Jun 30, 2013 | -113.39% |
| Mar 31, 2013 | -198.08% |
| Dec 31, 2012 | -126.80% |
| Sep 30, 2012 | -194.75% |
| Jun 30, 2012 | -268.54% |
| Mar 31, 2012 | -154.17% |
| Dec 31, 2011 | -94.67% |
| Sep 30, 2011 | -192.27% |
| Jun 30, 2011 | -93.72% |
| Mar 31, 2011 | -96.62% |
| Dec 31, 2010 | -116.83% |
| Sep 30, 2010 | -63.18% |
| Jun 30, 2010 | -45.12% |